Psychiatric medications for common mental health conditions — including antidepressants (SSRIs, SNRIs, bupropion), anxiolytics (buspirone, benzodiazepines short-term), mood stabilizers (lithium, valproate, lamotrigine), antipsychotics (first and second generation), and ADHD medications (stimulants, atomoxetine) — produce their effects through specific receptor-level mechanisms that modify neurotransmitter signaling, with the clinical evidence establishing their efficacy for specific conditions at specific severities while also identifying the limitations of medication-only approaches (not addressing underlying psychological patterns or social conditions), side effect profiles, and individual response variability.
Role
Psychiatric medication literacy — including understanding what medications do and do not do, their evidence bases, their limitations, and their appropriate role in a comprehensive treatment approach — is the health literacy competency that most reduces both the unnecessary medication avoidance (leaving people untreated who would benefit) and the medication over-reliance (treating symptoms without addressing underlying patterns) that characterize most people's relationship with psychiatric pharmacology. The accurate recognition that antidepressants produce meaningful improvement for approximately 60% of people at therapeutic doses — are not mood-elevating drugs that make everyone feel artificially happy, do not create dependency, and are not a sign of weakness — reduces the stigma and misconception that prevent most people who would benefit from ever trying medication-assisted treatment.